Literature DB >> 26626417

Ageing of people with Down's syndrome: a systematic literature review from 2000 to 2014.

Venusia Covelli1, Alberto Raggi, Paolo Meucci, Chiara Paganelli, Matilde Leonardi.   

Abstract

Life expectancy of people with Down's syndrome (DS) has increased considerably, now exceeding 60 years. People with DS start to get old around the age of 45. By referring to the WHO's International Classification of Functioning, Disability and Health (ICF) biopsychosocial perspective, this study aimed to present an up-to-date review of the past 14 years of literature concerning the ageing of people with DS. PUBMED, PsycInfo and the Social Sciences Citation Index were searched for studies published between 2000 and 2014. Studies were selected if they were written in English, focused on people more than 45 years of age with DS, and if terms related to DS and ageing appeared in either the title or the abstract. A total of 30 studies were retrieved and their meaningful concepts were linked to the ICF. In total, 38 ICF categories were identified that were mainly related to intellectual functions (b117) (19%), general metabolic functions (b540) (7.4%), mobility of joint functions (b710), muscle power functions (b730) (4.2%), gait pattern functions (b770) (4.2%) and structure of the brain (s110) (4.3%). Only two studies considered environmental factors, and only one considered the joint analysis of health condition and environmental factors. Data about the ageing of people with DS are predominantly based on medical evaluations and descriptions of their physical impairments. Few attempts have been made towards a comprehensive assessment of elderly people with DS with a joint analysis of their health condition and its interaction with environmental factors.

Entities:  

Mesh:

Year:  2016        PMID: 26626417     DOI: 10.1097/MRR.0000000000000147

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  10 in total

1.  Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.

Authors:  Eleonore Bayen; Katherine L Possin; Yingjia Chen; Laurent Cleret de Langavant; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

2.  Relationships of Body Composition to Cardiac Structure and Function in Adolescents With Down Syndrome are Different than in Adolescents Without Down Syndrome.

Authors:  Andrea Kelly; Samuel S Gidding; Rachel Walega; Claire Cochrane; Sarah Clauss; Ray R Townsend; Melissa Xanthopoulos; Mary E Pipan; Babette S Zemel; Sheela N Magge; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2018-11-01       Impact factor: 1.655

Review 3.  DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.

Authors:  Arnaud Duchon; Yann Herault
Journal:  Front Behav Neurosci       Date:  2016-06-03       Impact factor: 3.558

4.  Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.

Authors:  James H Cole; Tiina Annus; Liam R Wilson; Ridhaa Remtulla; Young T Hong; Tim D Fryer; Julio Acosta-Cabronero; Arturo Cardenas-Blanco; Robert Smith; David K Menon; Shahid H Zaman; Peter J Nestor; Anthony J Holland
Journal:  Neurobiol Aging       Date:  2017-04-18       Impact factor: 4.673

5.  Healthy Ageing in People with Intellectual Disabilities from Managers' Perspective: A Qualitative Study.

Authors:  Maria Johansson; Petra Björne; Ingrid Runesson; Gerd Ahlström
Journal:  Healthcare (Basel)       Date:  2017-08-18

Review 6.  Family Variables and Quality of Life in Children with Down Syndrome: A Scoping Review.

Authors:  Anna Lee; Kathleen Knafl; Marcia Van Riper
Journal:  Int J Environ Res Public Health       Date:  2021-01-07       Impact factor: 3.390

7.  Effects of Resistance Training in Muscle Mass and Markers of Muscle Damage in Adults with Down Syndrome.

Authors:  Antonio J Diaz; Ignacio Rosety; Francisco J Ordonez; Francisco Brenes; Natalia Garcia-Gomez; Cristina Castejon-Riber; Manuel Rosety-Rodriguez; Marco Bernardi; Jose Ramon Alvero-Cruz; Miguel A Rosety
Journal:  Int J Environ Res Public Health       Date:  2021-08-26       Impact factor: 3.390

8.  Cardiac Structure and Function in Adults with Down Syndrome.

Authors:  Fadi M Azar; Victor D Y Beck; Alice M Matthews; Daniel E Forsha; Thessa I M Hilgenkamp
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

Review 9.  Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease.

Authors:  Octavio García; Lisi Flores-Aguilar
Journal:  Front Cell Neurosci       Date:  2022-09-20       Impact factor: 6.147

10.  Heart rate and blood pressure in male Ts65Dn mice: a model to investigate cardiovascular responses in Down syndrome.

Authors:  Lara R DeRuisseau; Candace N Receno; Kevin S Heffernan; Caitlin M Cunningham
Journal:  Physiol Rep       Date:  2019-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.